Asle C. Hesla

436 total citations
14 papers, 268 citations indexed

About

Asle C. Hesla is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Asle C. Hesla has authored 14 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Rheumatology. Recurrent topics in Asle C. Hesla's work include Sarcoma Diagnosis and Treatment (9 papers), Bone Tumor Diagnosis and Treatments (4 papers) and Cancer-related molecular mechanisms research (3 papers). Asle C. Hesla is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Bone Tumor Diagnosis and Treatments (4 papers) and Cancer-related molecular mechanisms research (3 papers). Asle C. Hesla collaborates with scholars based in Sweden, Norway and Netherlands. Asle C. Hesla's co-authors include Panagiotis Tsagozis, Otte Brosjö, Andri Papakonstantinou, Felix Haglund, Yifan Zhang, Yi Chen, Nina Louise Jebsen, Olle Larsson, Yingbo Lin and Henrik C. F. Bauer and has published in prestigious journals such as Journal of Bone and Joint Surgery, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

Asle C. Hesla

14 papers receiving 263 citations

Peers

Countries citing papers authored by Asle C. Hesla

Since Specialization

Citations

This map shows the geographic impact of Asle C. Hesla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asle C. Hesla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asle C. Hesla more than expected).

Fields of papers citing papers by Asle C. Hesla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asle C. Hesla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asle C. Hesla. The network helps show where Asle C. Hesla may publish in the future.

Co-authorship network of co-authors of Asle C. Hesla

This figure shows the co-authorship network connecting the top 25 collaborators of Asle C. Hesla. A scholar is included among the top collaborators of Asle C. Hesla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asle C. Hesla. Asle C. Hesla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Wound healing after surgery for soft tissue sarcomas, and the effect of primary plastic reconstruction – A retrospective cohort study 2024 ·European Journal of Surgical Oncology ·(unknown), (unknown), Asle C. Hesla, (unknown), Jenny Löfgren	2
2	MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma 2024 ·Communications Biology ·(unknown), Paul Piccinelli, Shamik Mitra, (unknown), Asle C. Hesla, Camila Mattos, Jan De Koster, Linda Magnusson, (unknown), Adam Ameur, René Wardenaar, Floris Foijer, Diana C.J. Spierings, Fredrik Mertens	2
3	Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features 2024 ·The Journal of Pathology ·Shamik Mitra, (unknown), Paul Piccinelli, (unknown), Asle C. Hesla, (unknown), Fredrik Vult von Steyern, (unknown), Mikael Eriksson, Linda Magnusson, (unknown), Nischalan Pillay, Fredrik Mertens	2
4	TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma 2021 ·Modern Pathology ·Yifan Zhang, Yi Chen, Yang Chen, (unknown), Asle C. Hesla, (unknown), Olle Larsson, Yingbo Lin, Felix Haglund	25
5	Current Status of Management and Outcome for Patients with Ewing Sarcoma 2021 ·Cancers ·Asle C. Hesla, Andri Papakonstantinou, (unknown)	40
6	Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study 2020 ·British Journal of Cancer ·Asle C. Hesla, Andrea Discacciati, (unknown), Karin E. Smedby	6
7	Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency 2020 ·Molecular Oncology ·Yi Chen, Asle C. Hesla, Yingbo Lin, Mehran Ghaderi, Mingzhi Liu, Yang Chen, Yifan Zhang, (unknown), Olle Larsson, Felix Haglund	7
8	An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma 2019 ·Cancer Immunology Immunotherapy ·Panagiotis Tsagozis, Martin Augsten, Yifan Zhang, (unknown), Asle C. Hesla, Jonas Bergh, Felix Haglund, Nicholas P. Tobin, Monika Ehnman	34
9	Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas 2019 ·British Journal of Cancer ·Bertha Brodin, Krister Wennerberg, Elisabet Lidbrink, Otte Brosjö, Swapnil Potdar, Jennifer N. Wilson, Limin Ma, Lotte Moens, Asle C. Hesla, (unknown), (unknown), Andri Papakonstantinou, (unknown), (unknown), Karin von Sivers, Johan Wejde, Päivi Östling, Olli Kallioniemi, (unknown)	25
10	Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years 2018 ·Journal of bone oncology ·Asle C. Hesla, Øyvind S. Bruland, Nina Louise Jebsen, Emelie Styring, (unknown), Panagiotis Tsagozis	9
11	Telomerase promoter mutations and copy number alterations in solitary fibrous tumours 2018 ·Journal of Clinical Pathology ·Yingbo Lin, (unknown), (unknown), Asle C. Hesla, Mehran Ghaderi, Yi Chen, Monika Ehnman, (unknown), Johan Wejde, Olle Larsson, Felix Haglund	15
12	hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality 2018 ·Modern Pathology ·Yingbo Lin, (unknown), Yi Chen, Asle C. Hesla, Johan Wejde, Mehran Ghaderi, (unknown), Olle Larsson, Felix Haglund	12
13	Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones 2016 ·Journal of Bone and Joint Surgery ·Asle C. Hesla, Panagiotis Tsagozis, Nina Louise Jebsen, Olga Zaikova, Henrik C. F. Bauer, Otte Brosjö	27
14	Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts 2013 ·Acta Orthopaedica ·Otte Brosjö, (unknown), Asle C. Hesla, Panagiotis Tsagozis, (unknown)	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact